For better or worse? Telomerase inhibition and cancer.

doi:10.1016/s0092-8674(00)81955-8

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

For better or worse? Telomerase inhibition and cancer.

Cell - 6 Aug 1999

de Lange T, Jacks T

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin-Dependent Kinase Inhibitor p16
Share to Enzyme Inhibitors
Share to Mice
Share to Mice, Knockout

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mice, Mutant Strains

Share to Neoplasms

Share to Neoplasms, Experimental

Share to Telomerase

Source

Open in PubMed

Identifiers

PMID: 10458601
DOI: 10.1016/s0092-8674(00)81955-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

For better or worse? Telomerase inhibition and cancer.PMID 10458601Read ↗

Telomeres, telomerase, and cancer.Semantic proximity Read ↗

Is telomerase a viable target in cancer?Semantic proximity Read ↗

Targeting telomerase for cancer therapySemantic proximity Read ↗

Telomerase, cell immortality, and cancer.Semantic proximity Read ↗

Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular diseaseSemantic proximity Read ↗

Telomerase: A prominent oncological target for development of chemotherapeutic agentsSemantic proximity Read ↗

Pharmacological intervention strategies for affecting telomerase activity: Future prospects to treat cancer and degenerative diseaseSemantic proximity Read ↗

[Telomerase antagonists].Semantic proximity Read ↗

Telomerase inhibition, oligonucleotides, and clinical trialsSemantic proximity Read ↗

Targeting telomerase for cancer therapeuticsSemantic proximity Read ↗

A highly selective telomerase inhibitor limiting human cancer cell proliferationSemantic proximity Read ↗

Multiple Tumor Suppressor Pathways Negatively Regulate TelomeraseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.